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Decreased expression of the USP44 deubiquitinase
has been associated with global increases in
H2Bub1 levels during mouse embryonic stem cell
(mESC) differentiation. However, whether USP44
directly deubiquitinates histone H2B or how its
activity is targeted to chromatin is not known. We
identified USP44 as an integral subunit of the nuclear
receptor co-repressor (N-CoR) complex. USP44
within N-CoRdeubiquitinates H2B in vitro and in vivo,
and ablation of USP44 impairs the repressive activity
of the N-CoR complex. Chromatin immunoprecipita-
tion (ChIP) experiments confirmed that USP44
recruitment reduces H2Bub1 levels at N-CoR target
loci. Furthermore, high expression of USP44 corre-
lates with reduced levels of H2Bub1 in the breast
cancer cell line MDA-MB-231. Depletion of either
USP44 or TBL1XR1 impairs the invasiveness of
MDA-MB-231 cells in vitro and causes an increase
of global H2Bub1 levels. Our findings indicate that
USP44 contributes to N-CoR functions in regulating
gene expression and is required for efficient inva-
siveness of triple-negative breast cancer cells.
INTRODUCTION
Histone H2B is monoubiquitinated on lysine 123 in yeast and the
corresponding lysine 120 in mammals (hereafter referred to as
H2Bub1). H2Bub1 contributes to the creation of open and
accessible chromatin structures (Fierz et al., 2011), and it plays
important roles in transcriptional initiation and elongation (Henry
et al., 2003; Pavri et al., 2006; Xiao et al., 2005), mRNA process-
ing (Pirngruber et al., 2009), DNA damage response (Moyal et al.,2382 Cell Reports 17, 2382–2393, November 22, 2016 ª 2016 The A
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nance of stem cell multipotency (Fuchs et al., 2012; Karpiuk
et al., 2012). H2Bub1 is required in yeast and human cells for his-
tone H3 methylation on lysine 4 (H3K4) and lysine 79 (H3K79)
(Briggs et al., 2002; Ng et al., 2002; Sun and Allis, 2002; Wu
et al., 2011), which further contribute to transcriptional activity.
The importance of H2Bub1 to human health is highlighted by
several studies that indicate H2Bub1 levels are decreased in
many aggressive cancers, including colorectal cancer, metasta-
tic breast cancer, testicular seminoma, parathyroid cancer, and
lung cancer (Fuchs and Oren, 2014; Prenzel et al., 2011; Urasaki
et al., 2012).
H2Bub1 levels are governed by a balance in the activities of
specific ubiquitin ligases, such as RNF20/40 (Kim et al., 2005)
and deubiquitinases that target this modification. Several deubi-
quitinases, including USP22 (Zhang et al., 2008; Zhao et al.,
2008), USP27X, USP51 (Atanassov et al., 2016), USP3 (Nicassio
et al., 2007), USP7 (van der Knaap et al., 2010), USP42 (Hock
et al., 2014), and USP49 (Zhang et al., 2013), remove ubiquitin
from histone H2B. USP44 also has been implicated in H2Bub1
deubiquitination (Fuchs et al., 2012). In addition, USP44 func-
tions in DNA repair and in regulation of the spindle checkpoint
via Cdc20 deubiquitination (Mosbech et al., 2013; Stegmeier
et al., 2007). However, USP44 is not an active enzyme when in
isolation, indicating that this deubiquitinase (DUB), as previously
reported for other USPs (Atanassov et al., 2016; Kee et al., 2010;
Lan et al., 2015; Lang et al., 2011; Zhang et al., 2013), requires
activating cofactor proteins to productively engage its sub-
strates for deubiquitination.
Herewe report the use of tandemaffinity purification andmulti-
dimensional protein identification technology (MudPIT) to identify
USP44-interacting proteins. We found that USP44 interacts
with several components of the nuclear receptor co-repressor
complex (hereafter N-CoR complex). As part of N-CoR, USP44
deubiquitinates H2B both in vivo and in vitro, and it contributes
to N-CoR-mediated repression of target genes, including author(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
genome-integrated luciferase reporter (Vaquero et al., 2004)
and the endogenous Angptl4 gene (Jin et al., 2011). Chromatin
immunoprecipitation (ChIP) experiments revealed that USP44
is recruited to N-CoR target loci, where it deubiquitinates
histone H2B.
USP44 has been reported to be a marker for breast cancer
stem cells (Liu et al., 2015). Interestingly, depletion of the
N-CoR component, TBL1XR1, which is also highly expressed
in breast cancer cells (Kadota et al., 2009; Li et al., 2014), also
leads to increased global H2Bub1 levels. Overall, our study dem-
onstrates that USP44 associates with the N-CoR complex to
regulate H2Bub1 levels at N-CoR target genes and that compro-
mising the function of USP44 or the N-CoR complex impairs the
invasiveness of breast cancer cells.
RESULTS
USP44 Is a Subunit of the N-CoR Complex
To further define USP44 functions, we tested the ability of re-
combinant USP44 to deubiquitinate H2Bub1 in vitro (Figures
S1A and S1B, compare lane 1 to lanes 2 and 3). Like most other
H2B DUBs identified to date (USP22, USP27x, USP49, and
USP51), we found that recombinant USP44 is not active in
isolation. The protein domain structure of USP44 is very similar
to that of the other H2B DUBs (Figure 1A) that require associa-
tion with partner proteins for full enzymatic activity (Lang et al.,
2011; Zhang et al., 2013), so we reasoned that USP44 also
might require partners to acquire enzymatic activity toward
H2Bub1. To test this idea, we used a proteomic approach to
identify USP44-interacting proteins. We isolated nuclear ex-
tracts from 293T cells that stably express USP44 fused with
N-terminal FLAG and hemagglutinin (HA) affinity tags (FH-
USP44), and then we performed tandem affinity purification
(TAP) followed by MudPIT analysis to uncover USP44-associ-
ated proteins. As expected, CETN2 (centrin2), the only known
USP44-interacting protein (Zhang et al., 2012), was one of the
major proteins identified (Figure 1B). Surprisingly, the majority
of the other USP44-associated proteins identified are subunits
of the N-CoR complex, including TBL1X, TBL1XR1, HDAC3,
NCOR1, and NCOR2 (also called SMRT) (Yoon et al., 2003).
Moreover, a number of proteasomal subunits, including
PSMC1, PSMC2, PSMC4, and PSMC5, which associate with
N-CoR for its degradation (Perissi et al., 2004), also were iden-
tified as USP44-interacting proteins. None of these USP44
partners were detected in the FH-vector control purified in par-
allel (Figure 1B).
To further explore possible connections among CETN2,
USP44, and N-CoR, we purified FH-tagged CETN2 from 293T
cells and analyzed the purified fractions by MudPIT. Consistent
with our results above, USP44 was detected as a CETN2-inter-
acting protein. Moreover, RAD23B and XPC, both of which are
known to form a complex with CETN2 in the nucleus (Nishi
et al., 2005), also were detected in the CENT2-precipitated frac-
tions. However, N-CoR complex subunits were not detected in
the CETN2 purification, and XPC and RAD23B were not found
in USP44-precipitated fractions (Figure 1B). Thus, these data
indicate that USP44 is likely part of two separate complexes,
associated with either CETN2 or N-CoR.To validate our MudPIT results, we immunoprecipitated
ectopically expressed USP44 from 293T nuclear extracts, and
we blotted the precipitated fractions for TBL1X, TBL1XR,
NCOR1, or HDAC3. These experiments confirmed interactions
between endogenous N-CoR complex subunits and FH-
USP44, but not another H2Bub1 DUB, USP22 (Figure 1C).
Reciprocal immunoprecipitation (IP) using a TBL1X-specific anti-
body pulled down FH-tagged USP44 (anti-HA blot) and endoge-
nous USP44, as well as other N-CoR complex subunits (Figures
1D and 1E). To further determine whether USP44 is an integral
component of the N-CoR complex, we performed gel filtration
using FLAG- and HA-purified USP44 eluates. Immunoblots of
column fractions showed that USP44 co-purifies with N-CoR
subunits (fractions 16 and 17), corresponding to the expected
molecular weight of the N-CoR complex (1.5–2 MDa) (Yoon
et al., 2003). Importantly, CETN2 was found mostly in fractions
that contained little or no N-CoR subunits (fractions 19–23) (Fig-
ure 1F), again indicating that USP44 forms separate complexes
with these proteins. Further cell fractionation experiments
confirmed associations of USP44 and N-CoR complex compo-
nents with chromatin (Figure S1D). Collectively, these results
demonstrate that USP44 associates with the N-CoR complex
independently of CETN2 in the nucleus, indicating that this
DUB likely functions in multiple processes.
USP44 Interacts Directly with WD40 Repeats in TBL1X
and TBLXR1
Several USPs interact with WD40 motif-containing proteins (Vil-
lamil et al., 2013). For example, WDR48 interacts with USP1,
USP12, and USP46 to activate their DUB activity (Cohn et al.,
2009; Yin et al., 2015). Interestingly, the N-CoR components
TBLX and TBL1XR1 contain WD40 repeats (Uniprot). Moreover,
TBL1X and TBL1XR1 were the top non-CETN2 USP44-interact-
ing proteins detected in our MudPIT analyses (Figure 1B). To
determine whether USP44 interacts directly with TBLX1 or
TBLXR1, we performed IP experiments using recombinant HA-
USP44 and FLAG-TBL1X/TBL1XR1 from baculovirus-infected
insect cells. Both TBL1X and TBL1XR1 interacted with USP44,
alone and together (Figure 2A). TBL1X and TBL1XR1 contain
multiple domains, including LisH domains, F-box domains, and
WD40 repeats (Figure 2B). Previous studies demonstrated that
the N termini of LisH and F-box domains bind to histones H2B
and H4 and also are required for assembly of the N-CoR com-
plex (Oberoi et al., 2011; Yoon et al., 2003).
To determine whether these domains or the C-terminal WD40
repeats of TBL1X/TBL1XR1 are required for interaction with
USP44, we created expression constructs for truncated forms
of TBLXR1 that contained either the N-terminal LisH and F-box
motifs (F1) or the C-terminal WD40 repeats (F2) fused to Gal4
(Figure 2B). Introduction of these constructs into 293T cells ex-
pressing FH-USP44 and subsequent FLAG -immunoprecipita-
tions revealed that full-length TBLXR1 and the C-terminal frag-
ment interacted with USP44, but the N-terminal TBL1XR1
construct did not (Figure 2C). These results indicate that the
WD repeats in TBXLR1 are both necessary and sufficient for
USP44 interaction. Nevertheless, an in vitro reconstituted com-
plex containing USP44, TBL1X, and/or TBLXR1 did not show
obviously different DUB activity toward H2Bub1 relative toCell Reports 17, 2382–2393, November 22, 2016 2383
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Figure 1. USP44 Associates with the N-CoR Complex
(A) Schematic representation shows the protein domain structures of USP44, USP49, USP22, USP27x, and USP51.
(B)Distributednormalized spectral abundance factor (dNSAF) of partial CETN2-associated polypeptides andUSP44-associatedpolypeptides identifiedbyMudPIT
analysis. Bait proteins are highlighted in red, components of the CETN2-XPC complex are highlighted in blue, and components of the N-CoR complex are in green.
(C) Immunoprecipitation (IP) from nuclear extract (NE) of NFH-USP44 293T cells using FLAG beads. pINTO-NFH empty vector-transfected cells were used as a
negative control. Precipitated proteins were resolved on SDS-PAGE and analyzed by western blot with the indicated antibodies. H3 serves as loading control.
NFH, N-terminal FLAG and HA tags.
(D) IP from NE of NFH-USP44 293T cells using TBL1X antibody, followed by western blot with the indicated antibodies, is shown.
(E) IP from NE of MDA-MB-231 cells using TBL1X antibody, followed by western blot with the indicated antibodies, is shown.
(F) Gel filtration analysis of tandem FLAG- and HA-purified NFH-USP44 complexes. Fractions were resolved on SDS-PAGE, followed by immunoblotting with the
indicated antibodies.
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Figure 2. WD40 Repeats of TBL1X/R1 Are Required for the Association of USP44 with the N-CoR Complex
(A) Immunoprecipitation of HA-USP44 from Sf21 cells expressing the indicated proteins. The HA-precipitated fractions were resolved on SDS-PAGE and probed
with HA (USP44) or with FLAG (TBL1X and TBL1XR1).
(B) A domain chart of TBL1X and TBL1XR1 proteins. Schematic representation of the TBL1XR1 deletion constructs used in (C) is presented at the bottom.
(C) NFH-USP44-expressing cells were transiently transfected with the indicated GAL4-TBL1XR1-expressing vectors. The USP44-interacting proteins were
precipitated using HA beads and purified fractions blotted anti-GAL4 (TBL1XR1, full length or indicated truncations). b-actin serves as loading control.USP44 alone (Figure S1C, compare lane 1 to lanes 2, 3, and 5),
indicating that interactions with TBL1X and TBLXR1 are required
for USP44 association with N-CoR but are not sufficient for
USP44 activation. Furthermore, ablation of USP44 did not alter
the steady-state levels of TBL1X and TBL1XR1 in mouse embry-
onic fibroblasts (MEFs) (Figure S2), indicating that the N-CoR
complex is not likely a target for USP44 DUB activity.
USP44 Deubiquitinates H2Bub1 as Part of N-CoR
To determine whether USP44 is active toward H2Bub1 in vivo,
we depleted USP44 in 293T cells using small hairpin RNAs
(shRNAs) (Figure 3A). Consistent with previous reports using
embryonic stem cells (ESCs) (Fuchs et al., 2012), depletion ofUSP44 led to a noticeable (2-fold) increase in H2Bub1 levels
in 293T cells (Figures 3A and 3B). To further address USP44
effects on H2Bub1, we overexpressed either wild-type (WT) or
a catalytic mutant (C282A) of USP44 (Figure 3C). Overexpres-
sion of WT USP44 led to an obvious decrease of H2Bub1 levels,
whereas overexpression of the C282A mutant did not (Figures
3C and 3D).
To more directly test the ability of USP44 to deubiquitinate
H2Bub1, we utilized our purified FH-USP44-N-CoR complex
for in vitro DUB assays using purified core histones as substrate
(Figure 3E). H2Bub1 immunoblots indicated that, relative to an
FH-vector control purified in parallel, increased amounts of FH-
USP44-N-CoR in the reaction led to decreased H2Bub1 levels.Cell Reports 17, 2382–2393, November 22, 2016 2385
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Figure 3. The USP44-N-CoR Complex Deubiquitinates H2B In Vivo and In Vitro
(A) 293T cells were infected with non-targeting shRNA (shControl) or USP44-targeting shRNA (shUSP44) expressing lentiviruses. Then 48 hr after the infection,
the KD efficiency of USP44 was detected by real-time qPCR using two different pairs of USP44 primers. GAPDH was used as the internal control for normali-
zation. Each value is themean of three technical replicates with error bars representing the SD. Ex 1/2, primers on exon 1 and 2 junction; ex 4/5, primers on exon 4
and 5 junction.
(B) The depletion of USP44 leads to a marked increase in global H2Bub1. H2B blots were used as a loading control.
(C) Expression levels of WT or catalytically inactive USP44 proteins in the cells used in (D) are shown.
(D) Expression of WT USP44, but not catalytic inactive USP44, reduces global levels of H2Bub1 in 293T cells. 13 and 23 indicate the amount of purified total
histones loaded.
(E and F) (E) Sequential FLAG- and HA-purified USP44 complex or (F) TBL1X complex from 293T cells was used for in vitro DUB assay, using histones as
substrate. Both complexes show activity toward H2Bub in vitro. 13 and 23 indicate the amount of purified complexes used in the assay. Blots were quantified
using ImageJ software in this and all other figures. Endo., endogenous.
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Figure 4. USP44 Facilitates the Repressive Activity of the N-CoR Complex through Deubiquitinating H2B
(A) Schematic representation of the luciferase reporter system. The red line under the scheme indicates the position of the ChIP primers used in the figure.
(B) Fold change in luciferase activity in cells expressing GAL4, GAL4-TBL1XR1, and GAL4-TBL1X, 24 hr after doxycycline (100 ng/mL) induction. The
repression extent compared with GAL4 control is indicated on the y axis (the lower the bar, the more repression of the reporter). Each value is the mean of
three independent measurements with error bars representing the SD. Expression levels of all GAL4-tagged proteins are shown at the bottom without () and
with (+) induction.
(legend continued on next page)
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To further test whether DUB activity is associated with the
N-CoR complex, we repeated these experiments using purified
N-CoR from 293T cells stably expressing FH-TBL1X (Figure S3).
Incubation of the FH-TBL1X-N-CoR complex with purified his-
tones again led to decreased levels of H2Bub1 (Figure 3F). More-
over, association with CETN2 did not affect the DUB activity of
USP44 in vitro (Figures S1A and S1B, compare lane 1 to lanes
4 and 5). These experiments indicate that USP44 is an active
deubiqutinase when associated with the N-CoR complex.
USP44 Enhances the Repressive Activity of N-CoR
Given that N-CoR functions as a transcriptional repressor
through recruitment of the histone deacetylase HDAC3 (Wong
et al., 2014), we next determined whether USP44 also contrib-
utes to N-CoR functions using a genome-integrated luciferase
reporter system as previously described (Vaquero et al., 2004)
(Figure 4A). We generated stable 293 T-Rex cells (Vaquero
et al., 2004) containing doxycycline-inducible expression con-
structs for GAL4-TBL1X, GAL4-TBL1XR1, or GAL4 alone. As ex-
pected, luciferase expression and activity was repressed upon
the induction of GAL4-TBL1X or GAL4-TBL1XR1 (Figure 4B).
We next examined the contribution of USP44 and TBL1XR1 to
the repressive activity of GAL4-TBL1XR1. Real-time qPCR and
immunoblot analyses confirmed the knockdown (KD) efficiency
of USP44 and GAL4-TBL1XR1 (Figure S4). As expected, the
depletion of TBL1XR1 led to a marked increase in luciferase ac-
tivity (Figure 4C). Interestingly, the depletion of USP44 also led to
a moderate increase in luciferase activity (Figure 4C). As GAL4-
TBL1XR1 is required for the recruitment of both USP44 and
HDAC3, the enhanced effect of TBLXR1 KD likely reflects the
loss of both HDAC3 and USP44.
We next confirmed promoter recruitment of USP44 together
with the N-CoR complex by ChIP-qPCR. As expected, upon
doxycycline induction, GAL4-TBL1XR1 and FLAG-HA-USP44
were both recruited to the thymidine kinase (TK) promoter that
drives the luciferase reporter (Figure 4D). In addition, histone
H3 acetylation at lysines 9 and 14 (H3K9/14ac), known sub-
strates of HDAC3 (Bhaskara et al., 2010), was reduced, consis-
tent with HDAC3 of N-CoR recruitment (Figure 4E). Moreover,
H2Bub1 also was reduced (Figure 4F), consistent with N-CoR
recruitment of USP44 at this locus. As expected, the depletion
of USP44 led to an increase in H2Bub1 at this promoter, but it
had no effect on the H3K9/14ac. Conversely, the depletion of
HDAC3 led to increased H3K9/14ac, but it had no effect on
H2Bub1 at the luciferase promoter (Figures 4G and 4H).
The N-CoR complex is required for transcriptional repres-
sion of unliganded peroxisome proliferator-activated receptor(C) Fold change in luciferase activity in GAL4-TBL1XR1 cells upon KD of USP44
expressing lentiviruses for 2 days, and then the GAL4-TBL1XR1 expression was in
luciferase activity was measured. Each value is the mean of three independent m
(D) ChIP experiments monitoring the occupancy HA-USP44 at the promoter of the
with doxycycline (GAL4-TBL1XR1) induction. Normal mouse IgG was used as a
(E and F) (E) ChIP monitoring the enrichment of H3K9/14ac or (F) H2Bub1 at the re
is shown.
(G and H) (G) Probing the levels of the H2Bub1 and (H) H3K9/14ac at the reporter
induction. Enrichment is shown as a percentage of either input, histone H3 in the
the average of three technical replicates with error bars indicating SD (*p value <
2388 Cell Reports 17, 2382–2393, November 22, 2016(PPAR) target genes (Krogsdam et al., 2002). PPARd is broadly
expressed inmost tissues and the activation of PPARd enhances
lipid metabolism. PPARd is highly expressed in MEFs, and it
functions as a transcription repressor through association with
HDAC3 and NCOR in the absence of ligand (Shi et al., 2002).
GW501516 (GW) is a highly specific synthetic PPARd ligand
and a promising drug candidate for obesity (Evans et al.,
2004). Upon ligand treatment, PPARd becomes an activator
and leads to abundant activation of target genes (Mandard
et al., 2004). Angiopoietin-like 4 (Angptl4, also named PGAR or
FLAF) is a well-characterized target gene of PPARd, and it is
one of the most significantly induced target genes upon GW
treatment in MEFs (Jin et al., 2011; Oliver et al., 2001).
To further validate the repressive activity of USP44 in the
context of the N-CoR complex in vivo, we asked if depletion of
Usp44 affects the repression of Angptl4. As expected, Angptl4
expression was significantly induced upon treatment with GW
ligand, and depletion of Tbl1xr1 led to a marked increase in
Angptl4 expression without or with GW treatment (Figures 5A
and 5B). Importantly, Angptl4 expression also was increased in
Usp44-null MEFs without or with ligand treatment compared
with WT MEFs (Figure 5C; Figure S3B), indicating that USP44
is required for full repression of this N-CoR target gene.
To test if USP44 is targeted to the promoter of Angptl4, we
generated a stable cell line expressing HA-tagged USP44 in
Usp44 knockout (KO) MEFs, and we utilized these cells for
ChIP-qPCR. These experiments confirmed that USP44 is re-
cruited to the promoter of Angptl4 gene (Figure 5D). Consis-
tently, uponGW treatment, enrichment of USP44was decreased
at this locus (Figure 5D). In addition, both H3K9/14ac and
H2Bub1 increased upon GW treatment (Figures 5E and 5F),
consistent with dissociation of the N-CoR complex, including
both HDAC3 and USP44, from this locus. Together with our
data obtained from the luciferase reporter system, these results
strongly indicate that both histone deacetylation and USP44-
mediated removal of H2Bub1 contribute to the repression of
N-CoR target genes.
USP44-N-CoR Complex Links H2Bub1 to the
Invasiveness of Triple-Negative Breast Cancer Cells
USP44 is highly expressed in breast cancer stem cells, and it
may contribute to breast cancer aggressiveness (Liu et al.,
2015). TBL1XR1 is overexpressed and involved in the aggres-
siveness of malignant breast cancer cells, including MDA-
MB-231 triple-negative cells (Li et al., 2014). Interestingly, we
found that USP44 mRNA levels are significantly higher and
H2Bub1 levels are lower (but H2Aub1 levels are similar) inor TBL1XR1. Cells were infected with shControl-, shUSP44-, or shTBL1XR1-
duced by adding 100 ng/mL doxycycline to the medium. After 24-hr induction,
easurements with error bars representing the SD.
reporter in GAL4-TBL1XR1 cells transiently expressing HA-USP44, without or
negative control in this experiment.
porter promoter in GAL4-TBL1XR1 cells, without or with doxycycline induction,
promoter in USP44- or HDAC3-depleted cells, with or without GAL4-TBL1XR1
case of H3K9/14ac or histone H2B in the case of H2Bub1. All values represent
0.05 and **p value < 0.01 by two-sided t test).
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Figure 5. USP44 Contributes to the Repressive Activity of the N-CoR Complex through Deubiquitinating H2B at the Promoter of PPARd
Target Gene Angptl4
(A) Immunoblots to demonstrate the efficiency of Tbl1xr1 silencing in MEFs are shown.
(B) MEFs were infected with shControl or shTbl1xr1 for 2 days, followed by DMSO or 100 nMGW501516 (GW) treatment for 24 hr. Total RNAwas isolated and the
mRNA levels of Angptl4 were determined by real-time qPCR.
(C) Real-time qPCR analysis of Angptl4 mRNA in Usp44 WT and Usp44 KOMEFs, without or with PPARd-specific ligand GW treatment at 100 nM for 24 hr. Two
independent primary Usp44 MEF lines and two independent immortalized MEF lines were analyzed.
(D) Anti-HA ChIP monitoring the occupancy of USP44 at the promoter of Angptl4 in MEFs stably expressing USP44-HA, without or with GW treatment, is shown.
(E and F) (E) ChIP monitoring the enrichment of H3K9/14ac or (F) H2Bub1 at the promoter of Angptl4 in MEFs, without or with GW treatment. ChIP enrichment is
shown as a percentage of either input, histone H3 in the case of H3K9/14ac or histone H2B in the case of H2Bub1. All values represent the average of three
technical replicateswith error bars indicating SD (*p value < 0.05 by two-sided t test). The ChIP primers used in this experiment locate at the promoter region of the
Angptl4 gene.
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Figure 6. USP44 Regulates the Invasiveness
of Breast Cancer Cells
(A) Real-time qPCR analysis of USP44 mRNA
in MCF10A cells and MDA-MB-231 cells. GAPDH
was used as an internal control.
(B) Histones purified from MCF10A and MDA-MB-
231 cells were resolved on SDS-PAGE and blotted
with anti-H2Bub or anti-H2Aub antibody. Total H2B
or H2A blots were used as the loading control.
(C) MDA-MB-231 cells stably expressing shControl
or two different shUSP44s were used to perform
the transwell invasion assay. After 48-hr incuba-
tion, cells invading to the bottom of Matrigel
chambers were stained with crystal violet.
(D) Histones purified from MDA-MB-231 cells sta-
bly infected with shControl or shUSP44 were
resolved on SDS-PAGE and blotted with the indi-
cated antibodies.
(E) Immunoblots to demonstrate silencing effi-
ciency of TBL1XR1 in MDA-MB-231 cells, using
two different shRNAs, are shown.
(F) Histones purified from MDA-MB-231 cells sta-
bly expressing shControl or shTBL1XR1 shRNA
were resolved on SDS-PAGE and blotted with the
indicated antibodies. Total H2B, H3, or H2A serves
as the loading control. 13 and 23 indicate the
amount of purified total histones.
(G) Model of the function of the USP44-N-CoR
complex in cells. The N-CoR complex binds chro-
matin through TBL1X/TBL1XR1, and it directly re-
cruits USP44 to deubiquitinate histone H2B and
HDAC3 to deacetylate histone H3K9/14 to repress
target gene transcription.MDA-MB-231 cells compared to MCF10A normal breast epithe-
lial cells (Figures 6A and 6B). The depletion of USP44 signifi-
cantly impaired the invasiveness of MDA-MB-231 cells in vitro,
and it led to an increase in global H2Bub1 levels (Figures 6C
and 6D; Figure S5). The depletion of TBL1XR1 also impaired
the invasiveness of these breast cancer cells (Figure S6), consis-
tent with a previous study (Kadota et al., 2009). Accordingly, we
found that depletion of TBL1XR1 also led to increased levels of
H2Bub1 and moderately increased levels of H3K9/14ac, but no
obvious change in H2Aub1 levels (Figures 6E and 6F). Together
our results indicate that USP44 contributes to N-CoR functions2390 Cell Reports 17, 2382–2393, November 22, 2016in regulating gene expression and in
modulating invasiveness of triple-negative
breast cancer cells.
DISCUSSION
The N-CoR complex functions as a co-
repressor for various transcription factors,
including nuclear receptors, through the
recruitment of HDACs (Wong et al.,
2014). Here we report that USP44 func-
tions as a second enzymatic subunit of
the N-CoR complex and that this complex
deubiquitinates histone H2B in vivo and
in vitro. Our results indicate that both thedeubiquitination of histone H2B by USP44 and deacetylation
of histone H3 by HDAC3 contribute to N-CoR-mediated tran-
scriptional repression (Figure 6G).
Several chromatin-modifying complexes contain multiple ac-
tivities, as we describe here for the USP44-N-CoR complex.
The SAGA complex, a well-characterized histone-modifying
complex, contains two enzymes, the histone acetyltransferase
Gcn5 and the histone deubiquitinase USP22 (Koutelou et al.,
2010). Moreover, the MOF-MSL complex is composed of the
MOF histone acetyltransferase and the MSL E3 ubiquitin ligase
(Wu et al., 2011). These multiple enzyme-containing complexes
reflect the functional coordination of complicated networks of
chromatin modifications that are required for the proper regula-
tion of gene transcription (Workman, 2016).
The N-terminal domains of TBL1X and TBL1XR previously
were reported to bind histone H2B and H4 (Yoon et al., 2003).
Here we found that the C-terminal WD40 repeat domains of
these proteins are required to recruit USP44. Given that
USP44 functions as a histone DUB, interaction with TBL1X and
TBL1XR1 could help USP44 target its substrates for deubiquiti-
nation. However, association with TBL1X and TBL1XR1 is not
enough to activate the DUB activity of USP44 in vitro (Fig-
ure S1C), indicating that additional partners are required. Future
work will determine which other subunits of N-CoR are needed
for USP44 activity and the structural basis for its activation.
A previous report of global proteomic analyses identified
interacting proteins for 75 human DUBs, including USP44, in
whole-cell lysates (Sowa et al., 2009). Themajor USP44-interact-
ing proteins identified were CETN2 and a number of mitochon-
drial proteins, such as MRPL40, MRPL23, and MRPL53. The
USP44-CETN2complex is known to play an important role in pre-
venting chromosome segregation errors during mitosis (Zhang
et al., 2012). The function of USP44 in association withmitochon-
drial proteins is not yet clear. However, no subunits of the N-CoR
complexwere identified,whichmight reflect the use ofwhole-cell
extracts rather thannuclear extracts asused in our study. Indeed,
noneof themitochondrial proteins identified in the previous study
were found in our MudPIT analyses. Together, these data sug-
gest that USP44 playsmultiple roles in different cellular compart-
ments by forming complexes with distinct partners.
Genome-wide ChIP sequencing (ChIP-seq) analyses in
human cells show that H2Bub1 is generally associated with
highly expressed genes, being enriched at the 50 beginnings of
transcribed regions and also broadly distributed throughout
gene bodies (Jung et al., 2012; Minsky et al., 2008). Several
studies have highlighted the important roles of H2Bub1 in tran-
scriptional elongation (Fleming et al., 2008; Pavri et al., 2006;
Zhang and Yu, 2011). However, the role of H2Bub1 at gene pro-
moters is less clear. It is still an open debate whether relatively
low H2Bub1 signals at gene promoters reflect enhanced deubi-
quitination activity at this region or low ubiquitination of promoter
nucleosomes. In yeast, cycles of H2B ubiquitination and deubi-
quitination are needed for a productive switch from transcription
initiation to elongation (Henry et al., 2003). Recent studies indicate
a direct link between H2B deubiquitination at promoter regions
and decreased transcription in Drosophila and mammalian cells
(Kessler et al., 2015; Sussman et al., 2013). In addition, in vitro
analyses using chemically defined nucleosome arrays containing
recombinant H2Bub1 (Fierz et al., 2011) demonstrated that
H2Bub1 can disrupt higher-order chromatin architectures,
facilitatingmore open, accessible conformations needed for tran-
scription.Our data indicate that theUSP44-N-CoRcomplex likely
represses transcription by removing H2Bub1 via USP44 and his-
tone acetylation via HDAC3 at the promoter.
Reduced global H2Bub1 levels have been observed inmultiple
advanced cancers, including breast cancer, lung cancer, colo-
rectal cancer, and seminoma (Fuchs and Oren, 2014), raising
the possibility that high levels of H2Bub1-specific DUBs could
play a causal role in tumor formation or progression. In supportof this notion, USP22, a well-known H2Bub1 DUB (Zhang
et al., 2008), is highly expressed in various aggressive cancers
and is part of an 11-gene death-from-cancer signature that de-
fines tumors with cancer stem cell phenotypes of aggressive
growth, metastasis, and resistance to therapy (Glinsky, 2006).
Interestingly, USP44 is overexpressed in human T cell leukemias
(Zhang et al., 2011). We report here that USP44 is also highly ex-
pressed in aggressive breast cancer MDA-MB-231 cells, leading
to low global H2Bub1 levels and contributing to the invasiveness
of these cells. Consistent with these findings, another essential
subunit of the N-CoR complex, TBL1XR1, is also highly ex-
pressed in advanced breast cancer cells and contributes to their
aggressiveness (Li et al., 2014).
The N-CoR complex is a well-documented co-repressor for
unliganded nuclear receptors, and our data demonstrate that
USP44 contributes to NCoR-mediated repression of the PPARd
target gene Angptl4. However, we were unable to detect an ef-
fect of USP44 depletion on the transcription of estrogen receptor
(ER) target genes in MCF7 cells (data not shown), which also in-
volves N-CoR. The expression of USP44 in MCF7 and MCF10-A
cells is very low (data not shown and Figure 6A). Interestingly, Liu
et al. (2015) reported that USP44 expression is significantly
upregulated in breast cancer stem cells derived fromMCF7 cells
and contributes to the aggressiveness of breast cancer cells.
Given that MDA-MB-231 cells are triple negative and lack ER
expression, USP44 and the N-CoR complex must function to
repress other types of genes in these cells. Also, USP44 can deu-
biquitinate non-histone substrates (Stegmeier et al., 2007), so
this DUB may contribute to cancer aggressiveness indepen-
dently of the N-CoR complex and H2B deubiquitination. Clearly,
additional studies are needed to fully understand the multiple
contributions of USP44 and other USPs to oncogenesis.EXPERIMENTAL PROCEDURES
Nuclear Extract Preparation, Affinity Purification for Gel Filtration,
Deubiquitination Assay, and MudPIT Analysis
The 293T cells stably expressing FLAG and HA-USP44, CETN2, TBL1X,
or TBL1XR1 were established after transfection with pINTO-N-FH-
USP44, pINTO-N-FH-CETN2, pINTO-N-FH-TBL1X, pINTO-N-FH-TBL1XR1,
or pINTO-N-FH empty vector and following selection in DMEM-H complete
medium containing 300 mg/mL Zeocin (Life Technologies, R25001) for
2–3 weeks. 20–40 3 15-cm plates of stable cells were used for one tandem
affinity purification experiment. Nuclear extracts were prepared as described
previously (Gao et al., 2014) with modifications.
Gel Filtration and MudPIT Analysis
FLAG-HA-USP44 complex was purified by FLAG-HA affinity purification from
nuclear extracts, and the eluted complex was loaded into a superdex 200 col-
umn and fractionated by size, as described previously (Lan et al., 2015).
Nuclear extracts were isolated from 293T cells stably expressing USP44
fused with N-terminal FLAG and HA affinity tags (FH-USP44), and then they
were analyzed by TAP followed byMudPIT to uncover USP44-associated pro-
teins. TAP of FH-tagged CETN2 (centrin2), the only known USP44-interacting
protein, also was performed, followed by MudPIT analysis. An FH-vector con-
trol was purified and analyzed in parallel (see the Supplemental Experimental
Procedures for details).
The complete mass spectrometry dataset (raw files, peak files, SEQUEST
search files, as well as DTASelect result files, and protein sequences fasta
file) are available at: ftp://MSV000080144@massive.ucsd.edu. Password
XL75987. Proteome Xchange: PXD004957.Cell Reports 17, 2382–2393, November 22, 2016 2391
Luciferase Activity Assay
The 293T-Rex-luciferase cells (Vaquero et al., 2004) stably transfected with
pINTO-GAL4 vector control or inserts of interest were treated with
100 ng/mL doxycycline for 24 hr. Induced cells were lysed by ice-cold lysis
buffer (Promega), and then 10–25 mg of the cell lysate was assayed for lucif-
erase activity using luciferase assay substrate (Promega), as described previ-
ously (Gao et al., 2014).
More detailed experimental procedures used in this work are presented in
the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.10.076.
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